Imaging scans can show and track the presence of prostate cancer. Tests may include: a digital rectal examination (DRE), in which a doctor will manually check for any abnormalities of the prostate with their finger a biomarker test checking the blood, urine, or body tissues of a person with cancer for chemicals unique to individuals with cancer If these tests show abnormal results, further tests will include: a PCA3 test examining the urine for the PCA3 gene only found in prostate cancer cells a transrectal ultrasound scan providing imaging of the affected region using a probe that emits sounds a biopsy, or the removal of 12 to 14 small pieces of tissue from several areas of the prostate for examination under a microscope These will help confirm the stage of the cancer, whether it has t u r prostate spread, and what treatment is appropriate. To track any spread, or metastasis, doctors may use a bone, CT scan, or MRI scan.
Outlook If the disease is found before it spreads to other t u r prostate organs in a process known as metastasis, the 5-year survival rate is 99 percent. Once the cancer metastasizes, or spreads, the 5-year survival rate is 29 percent. Regular screening can help detect prostate cancer while it Prostate ka upchar is still treatable. Risk factors The exact cause of t u r prostate prostate cancer is unclear, t u r prostate but there are many T u r prostate possible risk factors.
Age Prostate cancer is rare among men under the t u r prostate age of 45 years, t u r prostate but more common after T u r prostate the age of 50 years.
Prostate 911 ingredients
Prostate purpose
Adenoma of prostate cancer
Prostate 5 xl
G-csf prostate cancer
16.03.2018 - BEZPRIDEL |
Slow down and even you're more likely to get levels of PSA, a protein produced by the prostate. |
16.03.2018 - mulatka_girl |
Which part or all of your prostate cancer, talk to your tumour presses. |
No comments:
Post a Comment